Q1 2023

Visited Roatan, Honduras with Christine so that she could receive follistatin-344 gene therapy.

During their visit to Roatan, Honduras, Kenneth Scott and his wife Christine Scott had a specific purpose in mind: to explore the pioneering work of Minicircle, a method development company in the field of genetic enhancement. Minicircle has achieved a remarkable milestone by developing the world’s first reversible human genetic enhancement platform. This platform utilizes …

Visited Roatan, Honduras with Christine so that she could receive follistatin-344 gene therapy. Read More »

Therapies

Meeting with the management Team of Agua Via.

Kenneth Scott recently visited Agua Via, a groundbreaking water technology company. Impressed by their innovative one-atomic-layer thick membrane technology, Scott added Agua Via to his investment portfolio. With a mission to provide abundant, low-cost, and pure water using minimal energy, Agua Via aims to address global water scarcity and pollution. Scott’s visit allowed him to …

Meeting with the management Team of Agua Via. Read More »

Made a presentation of a talk “Take Control of Your Body and Rejuvenate” to the People Unlimited community in Scottsdale AZ

Entrepreneur, investor, and biotech enthusiast Kenneth Scott delivered an engaging presentation at People Unlimited on the topic of rejuvenation and longevity. He expressed his excitement about the day’s events and shared insights from his conversation with the guest speaker. Kenneth Scott emphasized the importance of constantly improving oneself and getting better in every possible way. …

Made a presentation of a talk “Take Control of Your Body and Rejuvenate” to the People Unlimited community in Scottsdale AZ Read More »

Meeting with the CEOs of the companies we are investing.

Recently, Kenneth Scott had the opportunity to meet and engage with key stakeholders and CEOs of several notable companies in which VivaSparkle, has made strategic investments . These meetings provided valuable insights into the progress and potential of each company. Repair Biotechnologies, for instance, is focused on developing the Cholesterol Degrading Platform (CDP) to address …

Meeting with the CEOs of the companies we are investing. Read More »

Kenneth Scott was appointed as Advisor for LentoBio

Lento Bio, an early-stage pharmaceutical research company specializing in small molecule drugs for age-related diseases, has made significant strides in its development through two major announcements. Firstly, they have established an official scientific collaboration with Florida State University, focusing on medicinal chemistry and rational asset development. Led by Dr. James Frederich, a renowned expert in …

Kenneth Scott was appointed as Advisor for LentoBio Read More »

Submitted MyDNAge and Spectracell Telomere test samples as part of the ongoing trial of Khavinson peptides

In the ongoing trial of Khavinson peptides, Kenneth Scott recently participated by submitting both the myDNAge® Test and the Telomere Test. Khavinson peptides are derived from the research of Dr. Vladimir Khavinson and are known to mimic natural peptides found in the body. This trial aims to evaluate the efficacy of Khavinson peptides in optimizing …

Submitted MyDNAge and Spectracell Telomere test samples as part of the ongoing trial of Khavinson peptides Read More »

Worked with Edgar Masson of Xtend Clinic in Panama City to help launch their exciting new Longevity Clinic

Edgar Masson, CEO of Xtend Clinic in Panama City, has successfully launched their new Longevity Clinic, which focuses on age-related health. With his extensive expertise in the field of biotech companies addressing age-related challenges, Kenneth Scott has been a valuable advisor to Edgar throughout the launch process. Providing valuable insights and guidance, Kenneth has contributed …

Worked with Edgar Masson of Xtend Clinic in Panama City to help launch their exciting new Longevity Clinic Read More »

Scroll to Top